Navigation Links
Amgen Foundation and Ashoka's Changemakers Announce Finalists in Patients | Choices | Empowerment Competition
Date:11/17/2010

ture consideration. The Amgen Foundation will consider awarding up to $1 million in grants to support promising innovations in patient empowerment submitted by qualifying nonprofit organizations.

About Ashoka's ChangemakersAshoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other.  Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker.   www.Changemakers.com

About The Amgen Foundation The Amgen Foundation (http://www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.Contacts:Delyse Sylvester

Kristen DavisDirector of Community

Sr. Manager, Corporate CommunicationsAshoka's Changemakers

Amgen(250) 352-0616

Tel: 805-447-3008(250) 551-0570

Email: kristend@amgen.comEmail: dsylvester@ashoka.org(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prn
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
2. Amgen Foundation Awards $4.5 Million Grant to MLA Partner Schools to Invest in LAs Promise
3. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
4. Amgen Announces Webcast of 2010 Third Quarter Financial Results
5. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
6. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
7. Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
8. Amgen and Pfizer Introduce Psophisticated Style: A Guide to Everyday Style and Psoriasis™ Hosted by Tim Gunn
9. Amgen to Present at the UBS Global Life Sciences Conference
10. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Amgen to Present at the Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... N.J. , March 26, 2015 IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... of ANDA submissions now pending at the FDA to ... CEO of the Company, commented, "On March 2, 2015, ...
(Date:3/26/2015)...  CNBC profiled MJ Freeway , a business software ... "How I Did It," which features companies with unique paths ... released yesterday, illustrates how two tech entrepreneurs from ... the marijuana industry. ... Poinsett and Jessica Billingsley used their experience in ...
(Date:3/26/2015)... 26, 2015 Editor Note: ... bottom . Investor-Edge has initiated coverage on ... Salix Pharmaceuticals Ltd (NASDAQ: SLXP ), Hospira Inc. ... ), and Akorn Inc. (NASDAQ: AKRX ). Free ... http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets declined on Wednesday, March ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5
... LITTLE FALLS, N.J., Feb. 2, 2011 Projects ... provider of continuing medical education (CME/CE) activities, previously ... game-changing Living Medical eTextbook. Now the iPhone app ... recognized by iMedicalApps ( www.imedicalapps.com ) as one ...
... and PRINCETON, N.J., Feb. 2, 2011 Eli Lilly ... Squibb Company (NYSE: BMY ) announced today ... two global Phase III studies evaluating necitumumab, an investigational ... cell lung cancer (NSCLC). (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) ...
Cached Medicine Technology:Living Medical eTextbook iPhone App from Projects In Knowledge® Named to Top 20 List of Free Medical Apps 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 3Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 4Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 5Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 6Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 7Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 8Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 9Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 10
(Date:3/27/2015)... San Diego, CA (PRWEB) March 27, 2015 ... will launch its Protect Our Children (POC) NOW! vitamin ... at the Medical University of South Carolina (MUSC), and ... POC will be available at no cost to a ... less gestation who live within these two service areas. ...
(Date:3/27/2015)... 27, 2015 When struck with the ... to know where to begin. The latest eBook ... accident attorney, offers accident victims a clear and concise ... to ensure their personal injury claim is seen through ... the first actions that should be taken immediately following ...
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for families on ... the game! It’s portable, lightweight and provides a wide range ... new line of specialty trail mixes that satisfy your hunger ... with nutritious, 100% all natural ingredients. , These tasty combinations ... and fiber to your diet and boost energy. The mixes ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Approximately ... for Healthy Kids Coalition Lobby Day to lobby ... Health Improvement Program (SHIP). Everlast Climbing was ... PE Bill SF343/HF498 which would strengthen physical education ... student assessments and other measures to strengthen physical ...
(Date:3/27/2015)... Since September 2014, the country singer has been traveling ... been in retirement for a period of 13 years. Many ... to touring, and concert events have been booking quickly in ... out for the two shows recently scheduled for May 8 ... inventory of discounted Garth Brooks tickets for sale. , The ...
Breaking Medicine News(10 mins):Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2
... Weinberg is the first recipient of the science prize inaugurated ... Eva Klein. The prize is awarded in person by Crown ... 2008. The prizewinner, who is to be a leading international ... Institutet in Stockholm for two weeks to give lectures and ...
... You Be Ready with that Confident ... ... Freshening Teeth Cleaners, an effective way to,clean teeth and freshen breath on-the-go. ... of,teeth, leaving them feeling smooth and clean., A great smile is ...
... /PRNewswire/ - There is new hope for vertigo,and ... DizzyFIX,patients with vertigo can now treat themselves. Studies ... visual device helps treat the most common,type of ... DizzyFIX has received a number of medical research ...
... Sequences of DNA in the human genome that originated ... our bodies and are even essential for a healthy ... of Microbiology Today. , Retrovirus infections represent the most ... its genome into the DNA of the host cell, ...
... REDWOOD CITY, Calif., Jan. 29 Maxygen, Inc.,(Nasdaq: ... of,improved protein drugs, will host a conference call to ... results at 11:30 a.m.,ET (8:30 a.m. PT) on Tuesday, ... host the call. A press release announcing,Maxygen,s fourth quarter ...
... Gross Proceeds Expected to Be Approximately $168.6 Million, ... or the "Company") announced today that it has agreed ... Investment Bank, as sole,underwriter, in an underwritten public offering. ... option to purchase up to an additional,585,000 shares of ...
Cached Medicine News:Health News:Kimberly-Clark Launches DentaBurst(TM) Freshening Teeth Cleaners 2Health News:All Star Sales Introduces DizzyFIX a New Treatment for Vertigo and Dizziness 2Health News:Maxygen to Host Fourth Quarter and Year End 2007 Financial Results Conference Call on February 12, 2008 2Health News:Ventas Enters Agreement to Sell Common Stock 2Health News:Ventas Enters Agreement to Sell Common Stock 3Health News:Ventas Enters Agreement to Sell Common Stock 4Health News:Ventas Enters Agreement to Sell Common Stock 5
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, low viscosity bone cement for syringe use with an average setting time of approx. 7-9 Min., 41.6g of powder and 16.4g of liquid....
... Featuring new technology, such as a ... shaft and lens housings, this arthroscope has ... accomplished by EO, Steris and steam autoclaving ... diameters. Light post/adapters to fit ACMI, Wolf, ...
... The Passport II delivery device is the ... for C11UB. Its simple-to-use syringe technology allows ... a small incision. The blue colored plunger ... to protect the haptics during insertion. The ...
Medicine Products: